Home > Healthcare > Pharmaceuticals > Finished Drug Form > Triptorelin Market

Triptorelin Market Share

Report ID: GMI5427
Published Date: Feb 2023
Report Format: PDF

Download Free Sample

Triptorelin Market Share

Some prominent triptorelin market players include

Varian Pharmed
Verity Pharmaceuticals Inc.
LGM Pharma.
Ipsen Pharma
BACHEM
Ferring B.V.
Merck & Co., Inc.
Taj Pharmaceuticals Limited
Dr. Reddy’s Laboratories Ltd.

Many of these companies are emphasizing partnership and collaborations to expand their industry influence. Citing an instance, Amneal Pharmaceuticals, an American pharma company, announced a long-term partnership agreement with Orion Corporation, a Finnish pharma company in January 2023, to commercialize many of Amneal’s complex generic products.

Through this agreement, the company’s complex generic programs will be displayed by Orion in New Zealand, Australia, and most parts of Europe. It will help the company reinforce its product portfolio in Europe.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for triptorelin held a valuation of over USD 910 million in 2022 and is projected to grow at over 5% CAGR from 2023 to 2032, on account of surging occurrence of endometriosis across the global female population.

The triptorelin market size from the intradermal segment is anticipated to grow at over 4.5% CAGR from 2023 to 2032, fueled by the growing number of hormone therapies performed annually across the globe.

Europe triptorelin business valuation is poised to surpass USD 370 million by 2032, owing to the growing prevalence of diseases such as cancer and endometriosis in the region, coupled with increasing government investments towards the health and well-being of its citizens.

Some of the major triptorelin industry contenders include Taj Pharmaceuticals Limited., Anhui Anke Bioengineering (Group) Co., Ltd., Biozenta Lifescience Pvt. Ltd, Azurity Pharmaceuticals, Inc., and Verity Pharmaceuticals Inc., among others.